Clinical stage ready medical device company for the treatment of obesity and type 2 diabetes. Proprietary, stent-like, endoscopically delivered device that mimics the MOA of gastric bypass surgery for the treatment of obesity and type-II diabetes. 500 million obese patients worldwide, 84 million type 2 diabetes patients, offers patients, providers, payors a simpler, safer, significantly less invasive and cost-effective alternative to surgery.